Well, we are now into the second half and still no announcement regarding the end or even the completion of subject enrolment for the current HIV trial.
While these trials are unpredictable in terms of the logistics of subject recruitment and lord knows Biotron has been plagued with delays since day one, management should hang their heads in shame at the level of communication that is not happening. Shareholders have a right to be kept informed regarding progress and why announced deadlines are not being met.
management disappoints again
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
